Eli Lilly launches its blockbuster weight loss drug Mounjaro in India | Company Business News

Mumbai: US drugmaker Eli Lilly & Co. brought its anti-obesity drug Mounjaro to India on Thursday,…

Kotak Equities is optimistic on Indian pharma despite US tariff uncertainties; Sun Pharma, Lupin, Cipla among top picks | Stock Market News

In light of uncertainties surrounding US tariffs on pharmaceuticals, Kotak Institutional Equities noted in a recent…

Cipla faces over ₹1 crore penalty by GST authority

Pharma major Cipla Ltd on Friday (December 20, 2024) said a fine of over ₹1 crore…

Top 5 debt-free stocks to watch out for in 2025

Debt-free companies are uniquely positioned to weather economic downturns since they aren’t burdened by interest payments…

Cipla Q1 Results Live : profit rise by 18.27% YOY | Mint

Cipla Q1 Results Live : Cipla declared their Q1 results on 26 Jul, 2024. The topline…

Cipla gets ₹773 crore demand notice from income tax department. Here’s why | Mint

Leading pharmaceutical manufacturer Cipla Ltd received an additional tax demand of ₹773.44 crore from the income…

Cipla promoters plan to sell 2.53% stake

Mumbai: The promoters of pharmaceutical major Cipla Ltd,  including Shirin Hamied, Samina Hamied, Rumana Hamied and…

Q4 Results Today: Tata Motors, BoB, ABB India and others to post earnings today

Q4 FY2024 Results: Tata Motors, Bank Of Baroda, ABB India, Union Bank of India, Cipla, Polycab…

Cipla, Aurobindo, Torrent are 3 picks of HSBC on healthy Q4 expectations

The strong growth in the US markets led by large product launches has helped drive earnings…